Amur Minerals Corporation (CRTX) - Total Liabilities

Latest as of June 2025: GBX583.34K GBX ≈ $70.98 USD

Based on the latest financial reports, Amur Minerals Corporation (CRTX) has total liabilities worth GBX583.34K GBX (≈ $70.98 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Amur Minerals Corporation (CRTX) equity growth momentum to track the company's year-over-year net asset growth rate.

Amur Minerals Corporation - Total Liabilities Trend (2016–2024)

This chart illustrates how Amur Minerals Corporation's total liabilities have evolved over time, based on quarterly financial data.

Amur Minerals Corporation Competitors by Total Liabilities

The table below lists competitors of Amur Minerals Corporation ranked by their total liabilities.

Company Country Total Liabilities
Seed Innovations Ltd
LSE:SEED
UK GBX153.00K
Biome Technologies Plc
LSE:BIOM
UK GBX3.23 Million
Beowulf Mining
LSE:BEM
UK GBX901.45K
Union Jack Oil plc
LSE:UJO
UK GBX2.25 Million
Tiger Royalties and investments Plc
LSE:TIR
UK GBX91.36K
Serinus Energy
LSE:SENX
UK GBX50.04 Million
Fadel Partners Inc
LSE:FADL
UK GBX6.56 Million
Tertiary Minerals Plc
LSE:TYM
UK GBX591.87K

Liability Composition Analysis (2016–2024)

This chart breaks down Amur Minerals Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Amur Minerals Corporation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.65 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amur Minerals Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amur Minerals Corporation (2016–2024)

The table below shows the annual total liabilities of Amur Minerals Corporation from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 GBX341.00K
≈ $41.49
-48.49%
2023-12-31 GBX662.00K
≈ $80.55
-13.54%
2022-12-31 GBX765.65K
≈ $93.16
-7.98%
2021-12-31 GBX832.07K
≈ $101.24
+7.91%
2020-12-31 GBX771.06K
≈ $93.82
-9.53%
2019-12-31 GBX852.24K
≈ $103.69
-69.00%
2018-12-31 GBX2.75 Million
≈ $334.48
+193.03%
2017-12-31 GBX938.14K
≈ $114.14
-75.64%
2016-12-31 GBX3.85 Million
≈ $468.54
--

About Amur Minerals Corporation

LSE:CRTX UK Biotechnology
Market Cap
$59.80K
GBX491.49 Million GBX
Market Cap Rank
#31464 Global
#1180 in UK
Share Price
GBX9.50
Change (1 day)
+0.00%
52-Week Range
GBX8.38 - GBX17.50
All Time High
GBX2425.08
About

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The c… Read more